{"entity":{"type":"insider","cik":"0001357610","url":"/insider/0001357610","json_url":"/insider/0001357610.json","name":"Ridgeback Capital Management LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":141,"n_filings":20,"first":"2008-01-16","last":"2012-02-09","span_basis":"filed_date"},"name_variants":[{"name":"Ridgeback Capital Management LP","source":"filing","n_filings":5,"first_seen":"2011-06-27","last_seen":"2012-02-09"},{"name":"Ridgeback Capital Management LLC","source":"filing","n_filings":15,"first_seen":"2008-01-16","last_seen":"2009-05-01"}],"transactions":[{"id":2995037,"accession":"0000932440-12-000050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000932440-12-000050","line_url":"/filing/0000932440-12-000050#line-3","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.; Ridgeback Capital Investments L.P.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47229.0,"shares_display":"47,229","price_per_share":14.8,"price_display":"14.80","price_state":"stated","total_value":698989.2,"total_display":"698,989.20","total_whole":"698,989","shares_owned_after":6842839.0,"shares_owned_after_display":"6,842,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-06","filed_date":"2012-02-09","scope":"insider"},{"id":2995034,"accession":"0000932440-12-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000932440-12-000050","line_url":"/filing/0000932440-12-000050#line-2","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.; Ridgeback Capital Investments L.P.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61949.0,"shares_display":"61,949","price_per_share":14.92,"price_display":"14.92","price_state":"stated","total_value":924279.08,"total_display":"924,279.08","total_whole":"924,279","shares_owned_after":6890068.0,"shares_owned_after_display":"6,890,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-03","filed_date":"2012-02-09","scope":"insider"},{"id":2995030,"accession":"0000932440-12-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-12-000050","line_url":"/filing/0000932440-12-000050#line-1","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.; Ridgeback Capital Investments L.P.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":15.03,"price_display":"15.03","price_state":"stated","total_value":49599.0,"total_display":"49,599.00","total_whole":"49,599","shares_owned_after":6952017.0,"shares_owned_after_display":"6,952,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-02","filed_date":"2012-02-09","scope":"insider"},{"id":2079398,"accession":"0000932440-12-000049","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000932440-12-000049","line_url":"/filing/0000932440-12-000049#line-5","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.; Ridgeback Capital Management LP","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192600.0,"shares_display":"192,600","price_per_share":13.94,"price_display":"13.94","price_state":"stated","total_value":2684844.0,"total_display":"2,684,844.00","total_whole":"2,684,844","shares_owned_after":6955317.0,"shares_owned_after_display":"6,955,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-04","filed_date":"2012-02-09","scope":"insider"},{"id":2079393,"accession":"0000932440-12-000049","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000932440-12-000049","line_url":"/filing/0000932440-12-000049","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.; Ridgeback Capital Management LP","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90800.0,"shares_display":"90,800","price_per_share":13.930925110132158,"price_display":"13.93","price_state":"stated","total_value":1264928.0,"total_display":"1,264,928.00","total_whole":"1,264,928","shares_owned_after":7173317.0,"shares_owned_after_display":"7,173,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-03","filed_date":"2012-02-09","scope":"insider","n_lines":3},{"id":2079383,"accession":"0000932440-12-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-12-000049","line_url":"/filing/0000932440-12-000049#line-1","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.; Ridgeback Capital Management LP","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29349.0,"shares_display":"29,349","price_per_share":13.69,"price_display":"13.69","price_state":"stated","total_value":401787.81,"total_display":"401,787.81","total_whole":"401,788","shares_owned_after":7238717.0,"shares_owned_after_display":"7,238,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-02","filed_date":"2012-02-09","scope":"insider"},{"id":2182205,"accession":"0000932440-12-000048","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-28","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2584.0,"shares_display":"2,584","price_per_share":13.81,"price_display":"13.81","price_state":"stated","total_value":35685.04,"total_display":"35,685.04","total_whole":"35,685","shares_owned_after":7268066.0,"shares_owned_after_display":"7,268,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-31","filed_date":"2012-02-09","scope":"insider"},{"id":2182200,"accession":"0000932440-12-000048","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-27","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":57646.0,"total_display":"57,646.00","total_whole":"57,646","shares_owned_after":7270650.0,"shares_owned_after_display":"7,270,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-28","filed_date":"2012-02-09","scope":"insider"},{"id":2182198,"accession":"0000932440-12-000048","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202300.0,"shares_display":"202,300","price_per_share":13.939911023232822,"price_display":"13.94","price_state":"stated","total_value":2820044.0,"total_display":"2,820,044.00","total_whole":"2,820,044","shares_owned_after":7274750.0,"shares_owned_after_display":"7,274,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-27","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182193,"accession":"0000932440-12-000048","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159900.0,"shares_display":"159,900","price_per_share":12.910881801125704,"price_display":"12.91","price_state":"stated","total_value":2064450.0,"total_display":"2,064,450.00","total_whole":"2,064,450","shares_owned_after":7536950.0,"shares_owned_after_display":"7,536,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-26","filed_date":"2012-02-09","scope":"insider","n_lines":3},{"id":2182185,"accession":"0000932440-12-000048","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-21","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":12.71,"price_display":"12.71","price_state":"stated","total_value":2542000.0,"total_display":"2,542,000.00","total_whole":"2,542,000","shares_owned_after":7636950.0,"shares_owned_after_display":"7,636,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-25","filed_date":"2012-02-09","scope":"insider"},{"id":2182181,"accession":"0000932440-12-000048","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-20","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26200.0,"shares_display":"26,200","price_per_share":11.99,"price_display":"11.99","price_state":"stated","total_value":314138.0,"total_display":"314,138.00","total_whole":"314,138","shares_owned_after":7836950.0,"shares_owned_after_display":"7,836,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-24","filed_date":"2012-02-09","scope":"insider"},{"id":2182139,"accession":"0000932440-12-000048","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-19","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8837.0,"shares_display":"8,837","price_per_share":11.85,"price_display":"11.85","price_state":"stated","total_value":104718.45,"total_display":"104,718.45","total_whole":"104,718","shares_owned_after":7863150.0,"shares_owned_after_display":"7,863,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-21","filed_date":"2012-02-09","scope":"insider"},{"id":2182135,"accession":"0000932440-12-000048","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-18","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17122.0,"shares_display":"17,122","price_per_share":12.39,"price_display":"12.39","price_state":"stated","total_value":212141.58,"total_display":"212,141.58","total_whole":"212,142","shares_owned_after":7871987.0,"shares_owned_after_display":"7,871,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-17","filed_date":"2012-02-09","scope":"insider"},{"id":2182130,"accession":"0000932440-12-000048","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-17","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38993.0,"shares_display":"38,993","price_per_share":12.23,"price_display":"12.23","price_state":"stated","total_value":476884.39,"total_display":"476,884.39","total_whole":"476,884","shares_owned_after":7889109.0,"shares_owned_after_display":"7,889,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-14","filed_date":"2012-02-09","scope":"insider"},{"id":2182126,"accession":"0000932440-12-000048","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-16","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21200.0,"shares_display":"21,200","price_per_share":11.84,"price_display":"11.84","price_state":"stated","total_value":251008.0,"total_display":"251,008.00","total_whole":"251,008","shares_owned_after":7928102.0,"shares_owned_after_display":"7,928,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-13","filed_date":"2012-02-09","scope":"insider"},{"id":2182120,"accession":"0000932440-12-000048","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27330.0,"shares_display":"27,330","price_per_share":11.440603732162458,"price_display":"11.44","price_state":"stated","total_value":312671.7,"total_display":"312,671.70","total_whole":"312,672","shares_owned_after":7949302.0,"shares_owned_after_display":"7,949,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-12","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182110,"accession":"0000932440-12-000048","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-13","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51472.0,"shares_display":"51,472","price_per_share":10.98,"price_display":"10.98","price_state":"stated","total_value":565162.56,"total_display":"565,162.56","total_whole":"565,163","shares_owned_after":7976632.0,"shares_owned_after_display":"7,976,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-10","filed_date":"2012-02-09","scope":"insider"},{"id":2182106,"accession":"0000932440-12-000048","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-12","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":17456.0,"total_display":"17,456.00","total_whole":"17,456","shares_owned_after":8028104.0,"shares_owned_after_display":"8,028,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-07","filed_date":"2012-02-09","scope":"insider"},{"id":2182103,"accession":"0000932440-12-000048","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62922.0,"shares_display":"62,922","price_per_share":10.899731731349926,"price_display":"10.90","price_state":"stated","total_value":685832.92,"total_display":"685,832.92","total_whole":"685,833","shares_owned_after":8042626.0,"shares_owned_after_display":"8,042,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-06","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182096,"accession":"0000932440-12-000048","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64717.0,"shares_display":"64,717","price_per_share":10.866961231206638,"price_display":"10.87","price_state":"stated","total_value":703277.13,"total_display":"703,277.13","total_whole":"703,277","shares_owned_after":8107643.0,"shares_owned_after_display":"8,107,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-05","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182086,"accession":"0000932440-12-000048","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32891.0,"shares_display":"32,891","price_per_share":11.682460551518652,"price_display":"11.68","price_state":"stated","total_value":384247.81,"total_display":"384,247.81","total_whole":"384,248","shares_owned_after":8157343.0,"shares_owned_after_display":"8,157,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-27","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182079,"accession":"0000932440-12-000048","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54948.0,"shares_display":"54,948","price_per_share":11.571611705612579,"price_display":"11.57","price_state":"stated","total_value":635836.92,"total_display":"635,836.92","total_whole":"635,837","shares_owned_after":8190234.0,"shares_owned_after_display":"8,190,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-26","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182072,"accession":"0000932440-12-000048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58528.0,"shares_display":"58,528","price_per_share":11.881257517769273,"price_display":"11.88","price_state":"stated","total_value":695386.24,"total_display":"695,386.24","total_whole":"695,386","shares_owned_after":8245182.0,"shares_owned_after_display":"8,245,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-23","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":2182065,"accession":"0000932440-12-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-12-000048","line_url":"/filing/0000932440-12-000048#line-1","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Investments L.P.; Ridgeback Capital Management LP; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Investments L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13355.0,"shares_display":"13,355","price_per_share":11.1,"price_display":"11.10","price_state":"stated","total_value":148240.5,"total_display":"148,240.50","total_whole":"148,241","shares_owned_after":8303710.0,"shares_owned_after_display":"8,303,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-22","filed_date":"2012-02-09","scope":"insider"},{"id":3429619,"accession":"0000932440-12-000047","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20200.0,"shares_display":"20,200","price_per_share":12.750346534653465,"price_display":"12.75","price_state":"stated","total_value":257557.0,"total_display":"257,557.00","total_whole":"257,557","shares_owned_after":8317065.0,"shares_owned_after_display":"8,317,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-30","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":3429613,"accession":"0000932440-12-000047","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-28","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":12.75,"price_display":"12.75","price_state":"stated","total_value":1275.0,"total_display":"1,275.00","total_whole":"1,275","shares_owned_after":8317165.0,"shares_owned_after_display":"8,317,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-30","filed_date":"2012-02-09","scope":"insider"},{"id":3429611,"accession":"0000932440-12-000047","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25047.0,"shares_display":"25,047","price_per_share":12.820337765001797,"price_display":"12.82","price_state":"stated","total_value":321111.0,"total_display":"321,111.00","total_whole":"321,111","shares_owned_after":8337212.0,"shares_owned_after_display":"8,337,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-26","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":3429606,"accession":"0000932440-12-000047","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-25","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":12.71,"price_display":"12.71","price_state":"stated","total_value":1016800.0,"total_display":"1,016,800.00","total_whole":"1,016,800","shares_owned_after":8362212.0,"shares_owned_after_display":"8,362,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-25","filed_date":"2012-02-09","scope":"insider"},{"id":3429604,"accession":"0000932440-12-000047","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31852.0,"shares_display":"31,852","price_per_share":13.049843023985934,"price_display":"13.05","price_state":"stated","total_value":415663.6,"total_display":"415,663.60","total_whole":"415,664","shares_owned_after":8442712.0,"shares_owned_after_display":"8,442,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-23","filed_date":"2012-02-09","scope":"insider","n_lines":2},{"id":3429599,"accession":"0000932440-12-000047","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-22","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":12.44,"price_display":"12.44","price_state":"stated","total_value":870800.0,"total_display":"870,800.00","total_whole":"870,800","shares_owned_after":8474064.0,"shares_owned_after_display":"8,474,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-22","filed_date":"2012-02-09","scope":"insider"},{"id":3429597,"accession":"0000932440-12-000047","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-21","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93600.0,"shares_display":"93,600","price_per_share":12.23,"price_display":"12.23","price_state":"stated","total_value":1144728.0,"total_display":"1,144,728.00","total_whole":"1,144,728","shares_owned_after":8544064.0,"shares_owned_after_display":"8,544,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-19","filed_date":"2012-02-09","scope":"insider"},{"id":3429595,"accession":"0000932440-12-000047","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-20","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99000.0,"shares_display":"99,000","price_per_share":12.45,"price_display":"12.45","price_state":"stated","total_value":1232550.0,"total_display":"1,232,550.00","total_whole":"1,232,550","shares_owned_after":8636664.0,"shares_owned_after_display":"8,636,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-18","filed_date":"2012-02-09","scope":"insider"},{"id":3429593,"accession":"0000932440-12-000047","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-19","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":12.42,"price_display":"12.42","price_state":"stated","total_value":12420.0,"total_display":"12,420.00","total_whole":"12,420","shares_owned_after":8637664.0,"shares_owned_after_display":"8,637,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-18","filed_date":"2012-02-09","scope":"insider"},{"id":3429590,"accession":"0000932440-12-000047","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-18","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":3250000.0,"total_display":"3,250,000.00","total_whole":"3,250,000","shares_owned_after":8735664.0,"shares_owned_after_display":"8,735,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-17","filed_date":"2012-02-09","scope":"insider"},{"id":3429587,"accession":"0000932440-12-000047","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000932440-12-000047","line_url":"/filing/0000932440-12-000047#line-17","is_derivative":false,"issuer_cik":"0001357610","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001357610","owner_cik":null,"owner_name":"Ridgeback Capital Management LP; Ridgeback Capital Investments L.P.; Ridgeback Capital Investments Ltd.","owner_display_name":"Ridgeback Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class B Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12765.0,"shares_display":"12,765","price_per_share":12.96,"price_display":"12.96","price_state":"stated","total_value":165434.4,"total_display":"165,434.40","total_whole":"165,434","shares_owned_after":8985664.0,"shares_owned_after_display":"8,985,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-15","filed_date":"2012-02-09","scope":"insider"}],"collapsed":true,"next_cursor":"2011-08-15|3429587","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Ten percent owner","n_filings":5,"first_seen":"2011-06-27","last_seen":"2012-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001076481","name":"SEQUENOM INC","url":"/issuer/0001076481","role":"Ten percent owner","n_filings":14,"first_seen":"2008-06-30","last_seen":"2009-05-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Ten percent owner","n_filings":1,"first_seen":"2008-01-16","last_seen":"2008-01-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001357610","retrieved_at":"2026-08-22T12:58:43+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}